SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
elva
Lv1
50 积分
2022-01-25 加入
最近求助
最近应助
互助留言
[The level of asthma control in China from a national asthma control survey]
23天前
已完结
Comparison of Adverse Events Between PARP Inhibitors in Patients with Epithelial Ovarian Cancer: A Nationwide Propensity Score Matched Cohort Study
1个月前
已完结
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
2个月前
已完结
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low–Tumor Burden Follicular Lymphoma
4个月前
已完结
Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study
4个月前
已完结
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer
4个月前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
4个月前
已完结
Exploring DESTINY: the Past, Present, and Future of Trastuzumab Deruxtecan
5个月前
已完结
Breaking barriers in Triple Negative Breast Cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs)
5个月前
已完结
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer
6个月前
已完结
没有进行任何应助
下载不了
1年前
速度真快
2年前
文章没有全文
2年前
不是浙江医学的,是中华外科杂志里面的那篇
2年前
不是全文呀
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论